Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Viral load news

Show

From To
Viral load as low as 400 copies/ml six months after starting ART is associated with a significant ten-year mortality risk

A viral load as low as 400 copies/ml six months after starting HIV therapy is associated with a substantial ten-year mortality risk, investigators from the

Published
05 July 2017
By
Michael Carter
HIV drug resistance testing not a priority for resource-limited settings, trial finds

Resistance testing is unlikely to improve the effectiveness of second-line HIV treatment in resource-limited settings and the introduction of routine HIV drug resistance testing is

Published
14 June 2017
By
Keith Alcorn
Protease inhibitor drug suppresses HIV in semen more slowly than drugs from other classes

Protease inhibitors may not be the best class of drug for people newly diagnosed with HIV to start treatment with, if they wish to quickly

Published
12 May 2017
By
Gus Cairns
Time spent by people in HIV care in US with a transmissible viral load has fallen by three-quarters since 2000

A study by the US Centers for Disease Control and Prevention (CDC) presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2017) in Seattle found

Published
18 February 2017
By
Gus Cairns
Changes in viral suppression over time reveal disparities in HIV care in the United States

Sustained viral suppression over the course of a year may be a better measure than the most recent viral load test result when it comes to understanding

Published
15 February 2017
By
Liz Highleyman
People taking ART in the UK have an accurate understanding of their viral load

The vast majority of people taking antiretroviral therapy (ART) in the UK have an accurate knowledge of their current viral load (VL) level, investigators report

Published
16 January 2017
By
Michael Carter
Viral load testing capacity still weak in sub-Saharan Africa, 7-country study finds

Viral load testing capacity is still weak in some of the countries with the highest burden of HIV infection in sub-Saharan Africa and needs urgent improvement, according

Published
04 January 2017
By
Keith Alcorn
HIV viral load testing capacities progress, require global support, multiple partners to reach 90-90-90 goals

Four of seven sub-Saharan African countries followed by researchers over the last year and a half now can track the effectiveness of HIV treatment among all patients receiving it with tests to measure the levels of virus in their bodies at least once a year, according to an update in last week’s Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Published
06 December 2016
From
Science Speaks
If at First an HIV Viral Load Blips, Test, Test (the Same Sample) Again

If an HIV-positive patient's viral load test results come back between 50 copies/mL and 200 copies/mL, consider retesting the same blood sample, Joseph Eron Jr., M.D., suggests. According to study results he presented at IDWeek 2016 on Oct. 28, the new test result may well show a viral load below 50 copies m/L, potentially altering the choices a clinician makes of how to approach that patient's care.

Published
09 November 2016
From
The Body Pro
Spanish study gives reassurance: small HIV blips do not predict treatment failure

A very low viral load (20-49 copies/ml) during HIV therapy does not increase the risk of the subsequent virological failure of treatment (viral load above 200 copies/ml), according

Published
21 September 2016
By
Michael Carter

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.